D. Phung

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL

Julie N. Graff, G. Baciarello, Andrew J. Armstrong et al. · Annals of Oncology · 2015 · 117 citations · Full text

Medicine, Oncology, Pharmacology +14

Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL

Alan H. Bryce, Joshi J. Alumkal, Andrew J. Armstrong et al. · Prostate Cancer and Prostatic Diseases · 2017 · 109 citations · Full text

Medicine, Oncology, Urology +16

Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer

Andrew J. Armstrong, Po‐Han Lin, Celestia S. Higano et al. · Annals of Oncology · 2018 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials

Fred Saad, Cristina Ivanescu, D. Phung et al. · Prostate Cancer and Prostatic Diseases · 2017 · 63 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial

Thomas J. Schnitzer, María Pueyo, H. Deckx et al. · Osteoarthritis and Cartilage · 2023 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16